Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shibata

Showing results (811-820 of 840) with videos related to

Pageof 84
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 1, 1981
[Behavioral and electroencephalographic effects of alprazolam and its metabolites (author's transl)]S Ueki, S Watanabe, T Yamamoto, et al.
Radiation Protection Dosimetry|December 26, 2013
Measurements of the neutron activation cross sections for Bi and Co at 386 MeVH Yashima, S Sekimoto, K Ninomiya, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2011
A phase I study of bortezomib and temozolomide in patients with advanced solid tumorsJ Portnow, P Frankel, S Koehler, et al.
Diabetes|May 20, 1999
Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the JapaneseI Iwata, S Nagafuchi, H Nakashima, et al.
Neuroscience|June 19, 2013
Differential cellular localization of antioxidant enzymes in the trigeminal ganglionH Sato, M Shibata, T Shimizu, et al.
Journal of Dental Research|March 2, 2018
Recurrent Spindle Cell Carcinoma Shows Features of Mesenchymal Stem CellsT Ouchi, S Morikawa, S Shibata, et al.
Journal of Dermatological Science|July 4, 1998
Increase in the peripheral lymphocyte populations expressing CD54 (ICAM-1) after hyperthermic isolated limb perfusion in patients with malignant melanoma: an analysis of four casesJ Nakayama, X C Guan, R Tominaga, et al.
Journal of Surgical Oncology|August 22, 2009
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle, M R Weiser, A Ter Veer, et al.
The Review of Scientific Instruments|November 7, 2012
Optical pyrometer system for collisionless shock experiments in high-power laser-produced plasmasT Morita, Y Sakawa, Y Kuramitsu, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeksJ D Roberts, S Shibata, D V Spicer, et al.
Pageof 84

Showing results (811-820 of 840) with videos related to

Sort By:
Pageof 84
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 1, 1981
[Behavioral and electroencephalographic effects of alprazolam and its metabolites (author's transl)]S Ueki, S Watanabe, T Yamamoto, et al.
Radiation Protection Dosimetry|December 26, 2013
Measurements of the neutron activation cross sections for Bi and Co at 386 MeVH Yashima, S Sekimoto, K Ninomiya, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2011
A phase I study of bortezomib and temozolomide in patients with advanced solid tumorsJ Portnow, P Frankel, S Koehler, et al.
Diabetes|May 20, 1999
Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the JapaneseI Iwata, S Nagafuchi, H Nakashima, et al.
Neuroscience|June 19, 2013
Differential cellular localization of antioxidant enzymes in the trigeminal ganglionH Sato, M Shibata, T Shimizu, et al.
Journal of Dental Research|March 2, 2018
Recurrent Spindle Cell Carcinoma Shows Features of Mesenchymal Stem CellsT Ouchi, S Morikawa, S Shibata, et al.
Journal of Dermatological Science|July 4, 1998
Increase in the peripheral lymphocyte populations expressing CD54 (ICAM-1) after hyperthermic isolated limb perfusion in patients with malignant melanoma: an analysis of four casesJ Nakayama, X C Guan, R Tominaga, et al.
Journal of Surgical Oncology|August 22, 2009
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle, M R Weiser, A Ter Veer, et al.
The Review of Scientific Instruments|November 7, 2012
Optical pyrometer system for collisionless shock experiments in high-power laser-produced plasmasT Morita, Y Sakawa, Y Kuramitsu, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeksJ D Roberts, S Shibata, D V Spicer, et al.
Pageof 84